Oglesby Cancer Research Building (formerly Manchester Cancer Research Centre)
The Manchester Cancer Research Centre (MCRC) was launched in 2006 as a partnership between The University of Manchester, Cancer Research UK and The Christie NHS Foundation Trust. It was renamed the Oglesby Cancer Research Building in November 2018 to honour the contribution of Michael Oglesby, his family, and the Oglesby Charitable Trust to cancer research in Manchester.
Its vision is to develop and implement an integrated personalised medicine strategy that spans the entire patient journey from diagnosis through to treatment, including surgery, radiotherapy and drug therapy, to improve patient outcomes.
The new 6,000m2 building opene din June 2015, will enable the Centre to increase its research output by creating space for an additional 150 scientists and around 100 other staff.
It will give scientists and clinicians the environment they need to improve understanding of how cancer develops, in order to translate basic and clinical research into new treatments that benefit cancer patients in Manchester and across the world.
The innovative design of the building not only aims to deliver modern facilities in which to undertake research and optimise the potential for effective collaboration, but also reflects the international status and forward-thinking nature of the MCRC.
It is hoped this development will foster the development of new ideas and progress through the collaboration that underpins the success of the Centre and its bench-to-bedside philosophy.